| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.19B | 32.81B | 32.70B | 31.49B | 29.89B | 29.05B |
| Gross Profit | 2.14B | 2.30B | 2.34B | 2.32B | 2.21B | 2.04B |
| EBITDA | 1.56B | 1.57B | 1.79B | 1.84B | 2.40B | 1.34B |
| Net Income | 331.00M | 242.00M | 137.00M | 207.00M | 677.00M | -208.00M |
Balance Sheet | ||||||
| Total Assets | 19.49B | 24.65B | 25.06B | 26.39B | 27.15B | 25.47B |
| Cash, Cash Equivalents and Short-Term Investments | 1.47B | 727.00M | 2.00B | 1.81B | 1.02B | 1.67B |
| Total Debt | 6.54B | 6.61B | 6.55B | 7.14B | 7.38B | 6.94B |
| Total Liabilities | 13.10B | 18.00B | 18.19B | 19.13B | 18.73B | 18.77B |
| Stockholders Equity | 6.39B | 6.65B | 6.87B | 7.25B | 8.42B | 6.70B |
Cash Flow | ||||||
| Free Cash Flow | 596.00M | 2.08B | 400.00M | 1.66B | 202.00M | 1.50B |
| Operating Cash Flow | 1.28B | 2.69B | 1.97B | 2.39B | 896.00M | 2.10B |
| Investing Cash Flow | -1.50B | -787.00M | -1.01B | -725.00M | -651.00M | -575.00M |
| Financing Cash Flow | -1.14B | -1.12B | -282.00M | -960.00M | -1.02B | -1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £2.74B | 8.36 | 15.07% | 2.06% | 6.96% | 28.47% | |
74 Outperform | £29.21B | 7.58 | 13.57% | 3.25% | 1.05% | -20.25% | |
70 Outperform | £7.38B | 11.60 | 5.08% | 4.02% | 0.82% | 160.81% | |
68 Neutral | £1.51B | 14.01 | 20.47% | 3.34% | 8.06% | 5.15% | |
66 Neutral | £1.59B | 12.40 | 34.27% | 17.38% | 1.74% | -23.72% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | £1.54B | 3.62 | 24.47% | ― | ― | ― |